Correction to: Elevated TRIP13 drives the AKT/mTOR pathway to induce the progression of hepatocellular carcinoma via interacting with ACTN4

Ítems similars

• Elevated TRIP13 drives the AKT/mTOR pathway to induce the progression of hepatocellular carcinoma via interacting with ACTN4
  per: Zhu, Meng-Xuan, et al.
  Publicat: (2019)
• Correction to: Elevated TRIP13 drives the AKT/mTOR pathway to induce the progression of hepatocellular carcinoma via interacting with ACTN4
  per: Meng-Xuan Zhu, et al.
  Publicat: (2019-10-01)
• Crocin induces autophagic apoptosis in hepatocellular carcinoma by inhibiting Akt/mTOR activity
  per: Yao, Chong, et al.
  Publicat: (2018)
• Elevation of MAP17 enhances the malignant behavior of cells via the Akt/mTOR pathway in hepatocellular carcinoma
  per: Chen, Xinhuang, et al.
  Publicat: (2017)
• Elevated TRIP13 drives cell proliferation and drug resistance in bladder cancer
  per: Lu, Sicheng, et al.
  Publicat: (2019)